Historical shareholding details of Raymond James & Associates holdings in Brainstorm Cell Therapeutics, Inc. (BCLI)

Monthly changes of Raymond James & Associates shareholding in Brainstorm Cell Therapeutics, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Jun 30, 2024 Raymond James & Associates 111,285 0.13%
Mar 31, 2024 Raymond James & Associates 113,785 0.14%
Dec 31, 2023 Raymond James & Associates 115,785 0.17%
Sep 30, 2023 Raymond James & Associates 137,860 0.28%
Jun 30, 2023 Raymond James & Associates 164,603 0.37%
Mar 31, 2023 Raymond James & Associates 164,703 0.37%

View all ownership details of Brainstorm Cell Therapeutics, Inc.